CL Rohlfing, HM Wiedmeyer, RR Little, JD England … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— The DCCT was a multicenter, randomized clinical trial
designed to compare intensive and conventional therapies and their relative effects on the development
and progression of diabetic complications in patients with type 1 diabetes. Quarterly HbA ... Cited by 435 - Related articles - BL Direct - All 9 versions
C Trial - Diabetes Care, 2002 - Am Diabetes Assoc Page 1. Defining the Relationship Between Plasma Glucose and HbA 1c Analysis of glucose
profiles and HbA 1c in the Diabetes Control and Complications Trial C URT L. R OHLFING ,
BES H SIAO -M EI W IEDMEYER , MS R ANDIE R. L ITTLE , PHD ... Related articles - All 4 versions
A Avignon, A Radauceanu, L Monnier - Diabetes care, 1997 - Am Diabetes Assoc OBJECTIVE: To evaluate the relative value of plasma glucose (PG) at different time points in
assessing glucose control of type 2 diabetic patients. RESEARCH DESIGN AND METHODS:
Glycemic profiles, ie, PG at prebreakfast (8:00 AM), prelunch (11:00 AM), postlunch (2:00 ... Cited by 288 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org E Bonora, F Calcaterra, S Lombardi, N Bonfante, G … - Diabetes care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Daily glucose profiles were assessed in
non–insulin-treated type 2 diabetic patients. Outpatients at the diabetes clinic (n = 371; one daily
plasma glucose profile) and at home (n = 30; five daily blood glucose profiles over 1 ... Cited by 131 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org L Monnier, H Lapinski, C Colette - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In 290 non–insulin- and non–acarbose-using patients
with type 2 diabetes, plasma glucose (PG) concentrations were determined at fasting (8:00
am.) and during postprandial and postabsorptive periods (at 11:00 am., 2:00 pm, and ... Cited by 554 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org DE Goldstein, RR Little, RA Lorenz, JI Malone, D … - Diabetes care, 2004 - Am Diabetes Assoc The purpose of this review is to summarize current knowledge about the tests used most widely
in monitoring the glycemic status of people with diabetes. The review addresses both
patient- and physician/laboratory-based testing, and it includes tests of urine glucose and ... Cited by 385 - Related articles - BL Direct - All 10 versions
JM Hempe, R Gomez, RJ McCarter, SA Chalew - Journal of Diabetes and its …, 2002 - Elsevier This study tested the hypothesis that there are consistent individual differences in the relationship
between glycated hemoglobin (HbA1c) and mean blood glucose (MBG) levels in individuals
with similar preceding blood glucose levels. Blood glucose data were collected for up to ... Cited by 78 - Related articles - All 13 versions
- ►diabetesjournals.org [PDF] SA Chalew, JM Hempe, RJ McCarter - Diabetes Care, 2005 - Am Diabetes Assoc The antifungal agent itraconazole is considered safe in patients with dia- betes (1,2) but has
been associated with acute painful neuropathy in patients taking vincristine (3–5). We describe
a patient with diabetic neuropathy who de- veloped acute painful neuropathy with ... Cited by 72 - Related articles - BL Direct - All 7 versions
ES Kilpatrick, PW Maylor, BG Keevil - Diabetes Care, 1998 - Am Diabetes Assoc OBJECTIVE: To assess the inherent potential of glycated hemoglobin as a screening test for
type 2 diabetes by determining the biological variation in nondiabetic subjects. RESEARCH
DESIGN AND METHODS: HbA1c values were measured by high-performance liquid ... Cited by 100 - Related articles - BL Direct - All 7 versions
